Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/intestinal-and-hepatic-contributions-to-the-pharmacokinetic-aL2yZgn0A5
- Publisher
- Wiley
- Copyright
- Copyright © 2018 EVJ Ltd
- ISSN
- 0425-1644
- eISSN
- 2042-3306
- DOI
- 10.1111/evj.12796
- pmid
- 29239016
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Equine Veterinary Journal – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ; ;
Recommended Articles
Loading...
References
-
Efficacy of mass antimicrobial treatment of foals with subclinical pulmonary abscesses associated with Rhodococcus equiVenner, M.; Astheimer, K.; Lammer, M.; Giguere, S.
-
Rhodococcus equi pneumonia in the foal–part 2: diagnostics, treatment and disease managementMuscatello, G.
-
Macrolide antibiotics: binding site, mechanism of action, resistanceGaynor, M.; Mankin, A.S.
-
In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equiGiguere, S.; Lee, E.A.; Guldbech, K.M.; Berghaus, L.J.
-
Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foalsPeters, J.; Block, W.; Oswald, S.; Freyer, J.; Grube, M.; Kroemer, H.K.; Lammer, M.; Lutjohann, D.; Venner, M.; Siegmund, W.
-
Pharmacokinetics and pulmonary distribution of clarithromycin and rifampicin after concomitant and consecutive administration in foalsBerlin, S.; Spieckermann, L.; Oswald, S.; Keiser, M.; Lumpe, S.; Ullrich, A.; Grube, M.; Hasan, M.; Venner, M.; Siegmund, W.
-
Possible involvement of the drug transporters P glycoprotein and multidrug resistance‐associated protein Mrp2 in disposition of azithromycinSugie, M.; Asakura, E.; Zhao, Y.L.; Torita, S.; Nadai, M.; Baba, K.; Kitaichi, K.; Takagi, K.; Takagi, K.; Hasegawa, T.
-
Influence of solute carriers on the pharmacokinetics of CYP3A4 probesFranke, R.M.; Baker, S.D.; Mathijssen, R.H.; Schuetz, E.G.; Sparreboom, A.
-
OATP1B1 polymorphism as a determinant of erythromycin dispositionLancaster, C.S.; Bruun, G.H.; Peer, C.J.; Mikkelsen, T.S.; Corydon, T.J.; Gibson, A.A.; Hu, S.; Orwick, S.J.; Mathijssen, R.H.; Figg, W.D.; Baker, S.D.; Sparreboom, A.
-
The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3Seithel, A.; Eberl, S.; Singer, K.; Auge, D.; Heinkele, G.; Wolf, N.B.; Dorje, F.; Fromm, M.F.; Konig, J.
-
Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the ratGarver, E.; Hugger, E.D.; Shearn, S.P.; Rao, A.; Dawson, P.A.; Davis, C.B.; Han, C.
-
MDR‐ and CYP3A4‐mediated drug‐drug interactionsPal, D.; Mitra, A.K.
-
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liverVavricka, S.R.; Van, M.J.; Ha, H.R.; Meier, P.J.; Fattinger, K.
-
Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug‐drug interactionsChoi, M.K.; Jin, Q.R.; Choi, Y.L.; Ahn, S.H.; Bae, M.A.; Song, I.S.
-
Molecular mechanisms of drug transporter regulationTirona, R.G.
-
Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattleGiguere, S.; Huang, R.; Malinski, T.J.; Dorr, P.M.; Tessman, R.K.; Somerville, B.A.
-
Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foalsBerghaus, L.J.; Giguere, S.; Sturgill, T.L.; Bade, D.; Malinski, T.J.; Huang, R.
-
Concentration of the macrolide antibiotic tulathromycin in broncho‐alveolar cells is influenced by comedication of rifampicin in foalsVenner, M.; Peters, J.; Hohensteiger, N.; Schock, B.; Bornhorst, A.; Grube, M.; Adam, U.; Scheuch, E.; Weitschies, W.; Rosskopf, D.; Kroemer, H.K.; Siegmund, W.
-
4beta‐Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humansDiczfalusy, U.; Nylen, H.; Elander, P.; Bertilsson, L.
-
LC‐MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho‐alveolar cellsOswald, S.; Peters, J.; Venner, M.; Siegmund, W.
-
Rapid LC‐MS/MS method for the determination of 4‐hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foalsHasan, M.; Siegmund, W.; Oswald, S.
-
Pharmacokinetics and pulmonary distribution of gamithromycin after intravenous administration in foalsBerlin, S.; Randow, T.; Scheuch, E.; Grube, M.; Venner, M.; Siegmund, W.
-
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilutionRennard, S.I.; Basset, G.; Lecossier, D.; O'Donnell, K.M.; Pinkston, P.; Martin, P.G.; Crystal, R.G.
-
Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foalsJacks, S.; Giguere, S.; Gronwall, P.R.; Brown, M.P.; Merritt, K.A.
-
Expression of organic anion transporting polypeptide 1A2 in red blood cells and its potential impact on antimalarial therapyHubeny, A.; Keiser, M.; Oswald, S.; Jedlitschky, G.; Kroemer, H.K.; Siegmund, W.; Grube, M.
-
Long term cultures of primary human hepatocytes as an alternative to drug testing in animalsUllrich, A.; Stolz, D.B.; Ellis, E.C.; Strom, S.C.; Michalopoulos, G.K.; Hengstler, J.G.; Runge, D.
-
Hepatic blood flow in horses during the recuperative period from maximal exerciseDyke, T.M.; Hubbell, J.A.; Sams, R.A.; Hinchcliff, K.W.
-
Impact of regulatory polymorphisms in organic anion transporter genes in the human liverAoki, M.; Terada, T.; Ogasawara, K.; Katsura, T.; Hatano, E.; Ikai, I.; Inui, K.
-
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta‐lactamsBolhuis, M.S.; Panday, P.N.; Pranger, A.D.; Kosterink, J.G.; Alffenaar, J.W.
-
Antibacterial macrolides: a drug class with a complex pharmacological profileAbu‐Gharbieh, E.; Vasina, V.; Poluzzi, E.; De, P.F.
-
Pharmacological indices and pulmonary distribution of rifampicin after repeated oral administration in healthy foalsBerlin, S.; Kirschbaum, A.; Spieckermann, L.; Oswald, S.; Keiser, M.; Grube, M.; Venner, M.; Siegmund, W.
-
Clinical pharmacokinetics of rifampicinAcocella, G.
-
Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage formsAgrawal, S.; Panchagnula, R.
-
Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestineDrozdzik, M.; Groer, C.; Penski, J.; Lapczuk, J.; Ostrowski, M.; Lai, Y.; Prasad, B.; Unadkat, J.D.; Siegmund, W.; Oswald, S.
-
Cloning/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP/SLCO membersGui, C.; Hagenbuch, B.